Methadone maintenance treatment: Is it possible to adapt the daily doses to the metabolic activity of the patient?

Therapeutic Drug Monitoring

Volumn 23, Issue 1, 2001, Pages 1-3

  Charlier, Corinne ^a,c   Dessalles, Marie Claire ^b   Plomteux, Guy ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Laboratoire de Biologie   (France)

^c CHU SART TILMAN   (Belgium)

Author keywords

Cortisol ratio; Metabolic pathway; Methadone; Serum concentration

Indexed keywords

17 HYDROXYCORTICOSTEROID; 6 HYDROXYHYDROCORTISONE; CORTICOSTEROID DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 3A4; HYDROCORTISONE DERIVATIVE; METHADONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; METABOLIC ACTIVATION; METABOLISM; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; URINALYSIS;

ADULT; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; HYDROCORTISONE; MALE; METHADONE; MIXED FUNCTION OXYGENASES; NARCOTICS; OPIOID-RELATED DISORDERS; PHENOTYPE;

EID: 0035134198     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200102000-00001     Document Type: Article

References (15)

1. Methadone dosage and retention of patients in maintenance treatment
2. Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial
3. Methadone maintenance: Does dose determine differences in outcome?
4. Methadone N-demethylation in human liver microsomes: Lack of stereoselectivity and involvement of CYP 3A4
5. The involvement of cytochromes P450 3A4 in the N-demethylation of LAAM, nor-LAAM and methadone
6. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
7. Cortisol production rate and the urinary excretion of 17-hydroxycorticosteroids, free cortisol, and 6β-hydroxycortisol in healthy elderly men and women
8. Assessment of urinary 6β-hydroxycortisol as in vivo index of mixed-function oxygenase activity
9. Determination of serum methadone with an immunologic kit and comparison with a liquid chromatography method
10. Methadone maintenance treatment: An update
11. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves
12. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program
13. The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone
14. Cortisol metabolism in human liver in vitro: Metabolite identification and inter-individual variability
15. The roles of P-glycoprotein and intracellular metabolism in intestinal absorption of methadone